Twenty-four-hour endothelin-1 secretory pattern in stroke patients

被引:17
作者
Franceschini, R
Gandolfo, C
Cataldi, A
Del Sette, M
Rolandi, A
Corsini, G
Rolandi, E
Barreca, T
机构
[1] Dept Internal Med, I-16132 Genoa, Italy
[2] Univ Genoa, Dept Neurosci & Neurorehabil, Genoa, Italy
关键词
endothelin-1; ischemic stroke; secretory profile;
D O I
10.1016/S0753-3322(01)00059-2
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Endothelin-1 (ET-1) is a potent and long-acting vasoconstrictor peptide, which may play a role in the pathophysiology of a number of diseases. Controversial data exist on its role in human ischemic stroke. in order to ascertain whether changes in ET-1 plasma levels occur in ischemic stroke, plasma ET-1 levels and mean arterial pressure were determined in 15 patients at their first ischemic cerebral infarction and in 15 control subjects, over a 24-hour period. In stroke patients, mean 24-hour plasma ET-1 levels (4.9 +/- 0.5 ng/L) were higher (P < 0.05) than in control subjects (3.2 +/- 0.3 ng/L), and correlated with the mean size of the lesion, but not with the severity score of the neurological deficit, These results support the hypothesis that ET-1 levels reflect an indicator function for the amount of damaged cerebral tissue rather than a pathophysiological role. (C) 2001 Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:272 / 276
页数:5
相关论文
共 21 条
  • [1] CLASSIFICATION OF SUBTYPE OF ACUTE ISCHEMIC STROKE - DEFINITIONS FOR USE IN A MULTICENTER CLINICAL-TRIAL
    ADAMS, HP
    BENDIXEN, BH
    KAPPELLE, LJ
    BILLER, J
    LOVE, BB
    GORDON, DL
    MARSH, EE
    KASE, CS
    WOLF, PA
    BABIKIAN, VL
    LICATAGEHR, EE
    ALLEN, N
    BRASS, LM
    FAYAD, PB
    PAVALKIS, FJ
    WEINBERGER, JM
    TUHRIM, S
    RUDOLPH, SH
    HOROWITZ, DR
    BITTON, A
    MOHR, JP
    SACCO, RL
    CLAVIJO, M
    ROSENBAUM, DM
    SPARR, SA
    KATZ, P
    KLONOWSKI, E
    CULEBRAS, A
    CAREY, G
    MARTIR, NI
    FICARRA, C
    HOGAN, EL
    CARTER, T
    GURECKI, P
    MUNTZ, BK
    RAMIREZLASSEPAS, M
    TULLOCH, JW
    QUINONES, MR
    MENDEZ, M
    ZHANG, SM
    ALA, T
    JOHNSTON, KC
    ANDERSON, DC
    TARREL, RM
    NANCE, MA
    BUDLIE, SR
    DIERICH, M
    HELGASON, CM
    HIER, DB
    SHAPIRO, RA
    [J]. STROKE, 1993, 24 (01) : 35 - 41
  • [2] Increasing plasma neopterin and persistent plasma endothelin during follow-up after acute cerebral ischemia
    Anwaar, I
    Gottsäter, A
    Lindgärde, F
    Mattiasson, I
    [J]. ANGIOLOGY, 1999, 50 (01) : 1 - 8
  • [3] ASPLUND K, 1985, STROKE, V16, P885
  • [4] Endothelin antagonists
    Benigni, A
    Remuzzi, G
    [J]. LANCET, 1999, 353 (9147) : 133 - 138
  • [5] HIGH PLASMA-LEVELS OF ENDOTHELIN-1 AND ATRIAL-NATRIURETIC-PEPTIDE IN PATIENTS WITH ACUTE ISCHEMIC STROKE
    ESTRADA, V
    TELLEZ, MJ
    MOYA, J
    FERNANDEZDURANGO, R
    EGIDO, J
    CRUZ, AF
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 1994, 7 (12) : 1085 - 1089
  • [6] Clinical evidence for a neuromodulator action of endothelin in the hypothalamic-pituitary-adrenal axis in man
    Haak, T
    Jungmann, E
    Haak, E
    Ehrlich, S
    Usadel, KH
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1997, 105 (01) : 46 - 52
  • [7] Plasma endothelin-1 levels neither increase nor correlate with neurological scores, stroke risk factors, or outcome in patients with ischemic stroke
    Haapaniemi, E
    Tatlisumak, T
    Hamel, K
    Soinne, L
    Lanni, C
    Opgenorth, TJ
    Kaste, M
    [J]. STROKE, 2000, 31 (03) : 720 - 725
  • [8] Hamann G F, 1993, J Stroke Cerebrovasc Dis, V3, P256, DOI 10.1016/S1052-3057(10)80070-9
  • [9] EFFECTS OF ENDOTHELIN ON BLOOD-VESSELS OF THE BRAIN AND CHOROID-PLEXUS
    KADEL, KA
    HEISTAD, DD
    FARACI, FM
    [J]. BRAIN RESEARCH, 1990, 518 (1-2) : 78 - 82
  • [10] Kanai H, 1996, CLIN NEPHROL, V46, P353